Back to top
more

Humana (HUM)

(Delayed Data from NYSE)

$256.14 USD

256.14
850,473

-0.48 (-0.19%)

Updated Aug 7, 2025 04:00 PM ET

After-Market: $256.25 +0.11 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 1% (243 out of 246)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Humana (HUM) Tops Q1 Earnings and Revenues, Lifts Guidance

by Zacks Equity Research

Humana's (HUM) Q1 draws stength from Medicare Advantage enrollment growth, solid segmental performances, lower taxes as well as a favorable impact of share buybacks.

    Zacks Equity Research

    Humana's (HUM) Q1 Earnings Top Estimates, Raises Guidance

    by Zacks Equity Research

    Humana's (HUM) Q1 earnings reflect Medicare Advantage enrollment growth and solid performance across all segments.

      Zacks Equity Research

      Why Humana Inc. (HUM) Might Surprise This Earnings Season

      by Zacks Equity Research

      Humana (HUM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP.

        Zacks Equity Research

        Humana (HUM) Q1 Earnings to Benefit From Medicare Business

        by Zacks Equity Research

        Humana (HUM) Q1 earnings should see upside from higher revenues in Retail segment, but investments may increase total expenses.

          Zacks Equity Research

          Will Teladoc (TDOC) Q1 Earnings Buoy On Severe Flu Season?

          by Zacks Equity Research

          We expect Teladoc's (TDOC) earnings to see an upside from the recent severe flu season,which should lead to higher patient visits.

            Zacks Equity Research

            Will Higher Medicare Revenues Aid Aetna (AET) Q1 Earnings?

            by Zacks Equity Research

            Aetna (AET) Q1 earnings should benefit from growth in its Medicare business and a lower tax rate, partly offset by a decline in revenues.

              Zacks Equity Research

              HCA Healthcare (HCA) to Report Q1 Earnings: What's in Store?

              by Zacks Equity Research

              HCA Healthcare (HCA) Q1 results should see an upside from flu-related activity and lower taxes, partly offset by pressure on volumes.

                Zacks Equity Research

                Tenet Healthcare's (THC) Q1 Earnings: Is a Beat in Store?

                by Zacks Equity Research

                Tenet Healthcare's (THC) earnings are likely to beat estimates in the first quarter, riding high on the robust performance of its Ambulatory segment.

                  Zacks Equity Research

                  Company News for Apr 24, 2018

                  by Zacks Equity Research

                  Companies in the news are: ALK,ASB,HSIC,HUM

                    Zacks Equity Research

                    Anthem (ANTM) Q1 Earnings: What's in Store for the Stock?

                    by Zacks Equity Research

                    Anthem's (ANTM) first-quarter earnings might gain from a solid Government business. However, persistent softness in Individual business is likely to affect overall results.

                      Zacks Premium Research headshot

                      Can Government Business Drive Centene's (CNC) Q1 Earnings?

                      by Zacks Premium Research

                      Centene's (CNC) first quarter 2018 results are likely to benefit from Medicaid expansion as well as rising participation in exchanges.

                        Zacks Equity Research

                        UnitedHealth (UNH) Q1 Earnings & Revenues Top, View Lifted

                        by Zacks Equity Research

                        UnitedHealth (UNH) Q1 earnings reflect double-digit growth across each business line.

                          Zacks Equity Research

                          UnitedHealth (UNH) Q1 Earnings to Gain From Optum Revenues

                          by Zacks Equity Research

                          UnitedHealth (UNH) Q1 earnings should see an upside from higher revenues in its health services segment named Optum.

                            Zacks Equity Research

                            Will UnitedHealth (UNH) Q1 Earnings Buoy on Revenue Growth?

                            by Zacks Equity Research

                            UnitedHealth's (UNH) Q1 earnings should see an upside from revenue growth at both its segments - Optum and UnitedHealthcare.

                              Mark Vickery headshot

                              Top Stock Reports for General Dynamics, Verizon & AIG

                              by Mark Vickery

                              Today's Research Daily features new research reports on 16 major stocks, including General Dynamics (GD), Verizon Communications (VZ) and American International Group (AIG).

                                Zacks Equity Research

                                Humana (HUM) Shores Up Government Business With FPG Buyout

                                by Zacks Equity Research

                                Humana's (HUM) Medicare business is expected to benefit from its strategic acquisitions.

                                  Zacks Equity Research

                                  Check These 3 Health Insurers to Reap High Returns in Q2

                                  by Zacks Equity Research

                                  We streamline our search to three best insurance bets with potential to turn investors rich by garnering fat returns.

                                    Zacks Equity Research

                                    Medicare Rate Up More than Expected, Health Insurers to Gain

                                    by Zacks Equity Research

                                    Increase in Medicare Advantage reimburse rates bodes well for health insurers.

                                      Zacks Equity Research

                                      Walmart Takes on Amazon Again, Look What It's Done This Time

                                      by Zacks Equity Research

                                      Walmart (WMT) plans to introduce Walmart2World money transfer service in collaboration with MoneyGram International.

                                        Zacks Equity Research

                                        Can Walmart Fortify Position Against Amazon With Humana Deal?

                                        by Zacks Equity Research

                                        Walmart's (WMT) plans to extend existing ties with Humana to enhance healthcare offerings, seems another bullet shot by the former in its war against the e-commerce king.

                                          Zacks Equity Research

                                          5 Reasons Why Anthem (ANTM) is a Lucrative Investment Option

                                          by Zacks Equity Research

                                          Anthem (ANTM) appears an impressive investment option on the back of rising membership, favorable investment income as well as solid financial health.

                                            Zacks Equity Research

                                            Humana (HUM) Up 3.2% Since Earnings Report: Can It Continue?

                                            by Zacks Equity Research

                                            Humana (HUM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                              Zacks Equity Research

                                              Select Medical (SEM) Q4 Earnings Top Estimates, Keeps View

                                              by Zacks Equity Research

                                              Solid segmental performances aid Select Medical's (SEM) Q4 earnings.

                                                Zacks Equity Research

                                                Anthem Buys America's 1st Choice, Expands in Medicare Market

                                                by Zacks Equity Research

                                                Anthem's (ANTM) acquisition of America's 1st Choice falls in line with its strategy to expand in the Medicare Advantage market.

                                                  Zacks Equity Research

                                                  Ensign Group (ENSG) Beats on Q4 Earnings, Raises '18 View

                                                  by Zacks Equity Research

                                                  Ensign Group's (ENSG) top line rises in Q4 on solid segmental revenues.